|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Interest-earning demand accounts | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Securities purchased under agreements to resell | ||||||||||||||||||||
| Mortgage loans in process of securitization | ||||||||||||||||||||
| Securities available for sale (includes $527,676 and $571,314 at fair value) | ||||||||||||||||||||
| Securities held to maturity (fair value of $1,353,543 and $1,543,554) | ||||||||||||||||||||
| Federal Home Loan Bank (FHLB) stock and other equity securities | ||||||||||||||||||||
| Loans held for sale (includes $148,368 and $76,980 at fair value) | ||||||||||||||||||||
| Loans receivable (includes $46,024 and $47,318 at fair value), net of allowance for credit losses on loans of $75,803 and $83,301 | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Servicing rights | ||||||||||||||||||||
| Interest receivable | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Other real estate owned | ||||||||||||||||||||
| Other assets and receivables | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Shareholders' Equity | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Deposits | ||||||||||||||||||||
| Noninterest-bearing | ||||||||||||||||||||
| Interest-bearing | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Borrowings | ||||||||||||||||||||
| Deferred and current tax liabilities, net | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders' Equity | ||||||||||||||||||||
| Common stock, without par value Authorized - 75,000,000 shares Issued and outstanding - 45,938,075 and 45,893,172 shares | ||||||||||||||||||||
| Preferred stock | ||||||||||||||||||||
| 7% Series A Preferred Stock | ||||||||||||||||||||
| 6% Series B Preferred Stock | ||||||||||||||||||||
| 6% Series C Preferred Stock | ||||||||||||||||||||
| 8.25% Series D Preferred Stock | ||||||||||||||||||||
| 7.625% Series E Preferred Stock | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total shareholders' equity | ||||||||||||||||||||
| Total liabilities and shareholders' equity | ||||||||||||||||||||
Loading...
